CA
TMDX icon

Continuum Advisory’s Transmedics TMDX Stock Holding History

Continuum Advisory’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$199 Buy
+3
New +$254 ﹤0.01% 1953
2025
Q2 		– Sell
-3
Closed -$202 – 1460
2025
Q1 		$202 Hold
3
– – ﹤0.01% 1626
2024
Q4 		$187 Sell
3
-17
-85% -$1.58K ﹤0.01% 1818
2024
Q3 		$1.77K Buy
20
+17
+567% +$2.62K ﹤0.01% 1482
2024
Q2 		$452 Sell
3
-1
-25% -$120 ﹤0.01% 1616
2024
Q1 		$515 Buy
+4
New +$330 ﹤0.01% 1600

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Continuum Advisory's TMDX Position: Q2 2026 in Review

Continuum Advisory opened a new position in Transmedics (TMDX) in Q2 2026: 3 shares worth $199. The stake represents ﹤0.01% of the portfolio and ranks #1953 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in TMDX as recently as Q1 2025.

Continuum Advisory first reported a position in TMDX in Q1 2024 and has held it in 6 quarters since. The position peaked at $1.77K in Q3 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Continuum Advisory held 3 shares of Transmedics worth $199 as of Q2 2026.
  • Transmedics was a new Continuum Advisory position in Q2 2026.
  • Transmedics made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1953 holding.
  • Continuum Advisory first reported a position in Transmedics in Q1 2024 and has held it in 6 quarters since.
  • Continuum Advisory's Transmedics position peaked at $1.77K in Q3 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.